SynOx Therapeutics
Developer of treatment for diffuse tenosynovial giant cell tumors.
7
Funding Rounds
$542.0m
Money raised
Funding series
Funding Series Analysis
The company SynOx Therapeutics has raised a total of $542m in funding over 7 rounds.
Key Insights:
- SynOx Therapeutics Series B Round, October 2024: $92m
- SynOx Therapeutics April 2024 Series B Funding Round: $75m
- SynOx Therapeutics April 2024 Series B Funding Round: $75m
- SynOx Therapeutics April 2024 Series B Funding Round: $75m
- SynOx Therapeutics April 2024 Series B Funding Round: $75m
- SynOx Therapeutics April 2024 Series B Funding Round: $75m
- SynOx Therapeutics April 2024 Series B Funding Round: $75m
SynOx Therapeutics Series B Round, October 2024
$92m
SynOx Therapeutics April 2024 Series B Funding Round
$75m
SynOx Therapeutics April 2024 Series B Funding Round
$75m
SynOx Therapeutics April 2024 Series B Funding Round
$75m
SynOx Therapeutics April 2024 Series B Funding Round
$75m
SynOx Therapeutics April 2024 Series B Funding Round
$75m
SynOx Therapeutics April 2024 Series B Funding Round
$75m
Industries
SynOx Therapeutics is active in the following industries: